Parents hoping to get their youngest children vaccinated against COVID-19 have some encouraging news
Pfizer said Monday, May 23, 2022, that three doses of its vaccines offers strong protection to those under 5. That news comes a month after Moderna said it would ask regulators to OK its two shot regimen for the youngest kids. encouraging newsPfizer said three small doses of its vaccine offers strong protection to youngsters under 5, according to preliminary data. That news comes a month after Moderna said it wouldBut a few steps remain before the shots are available.
Moderna is seeking clearance for two low-dose shots for children under age 6 while Pfizer hopes to offer three extra-low doses to kids under age 5 — differences due to how each company studied its vaccine. Currently the U.S. recommends vaccinations for everyone age 5 and older, and Pfizer is the only option for those children. Moderna for now is used only in adults in the U.S.
The CDC would convene its own panel of advisers to debate the recommendation before issuing its official guidance.The Biden administration has said the shots will roll out rapidly, and most tots are expected to be vaccinated in pediatricians' offices or health clinics. It’s not clear how much demand there will be to vaccinate the youngest kids, however. Pfizer shots for 5- to 11-year-olds opened in November, but only about 30% of that age group have gotten the recommended initial two doses.
Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Three-dose Covid-19 vaccine produces strong immune response in young children, Pfizer and BioNTech sayThree child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday. The vaccine makers said they will finish submitting the trial data to the US Food and Drug Administration this week.
Read more »
COVID-19 vaccine for kids under 5: Pfizer says 3 small doses offer strong protectionPfizer says it plans to give the data to U.S. regulators later this week. The 18 million tots under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.
Read more »
Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5A third pediatric dose of the Pfizer-BioNTech COVID-19 vaccine in children 6 months to under 5 years of age prompted a strong immune response, with a safety profile that was similar to placebo, the companies said:
Read more »
Biden: Monkeypox threat doesn’t rise to level of COVID-19President Joe Biden is seeking to calm concerns about recent cases of monkeypox that have been identified in Europe and the United States.
Read more »
Pfizer: 3 COVID-19 shots protect children under 5Pfizer says three small doses of its COVID-19 vaccine protect children under the age of 5 and that it plans to give the data to U.S. regulators later this week.
Read more »
Under-five COVID-19 vaccines near finish linePfizer will submit data to the FDA this week.
Read more »